TARGETING THE TUMOR MICROENBIRONMENT TO OPTIMIZE EPIGENETIC THERAPY AGAINST TRIPLE-NEGATIVE BREAST CANCER STEM CELLS

$605,624FY2013Department of the ArmyDOD

The Johns Hopkins University

Investigators